
Anduril vs Lockheed Martin - higher valuation on December 31?
Anduril vs Lockheed Martin - higher valuation on December 31?
AI analysis
The market resolves on a comparison of the two companies' valuations on December 31: which of Anduril or Lockheed Martin is valued higher. Lockheed Martin currently trades around 65%, even though it is a public company with a market capitalization in the roughly $100bn+ range, while Anduril remains private and its valuation is set only at funding rounds. Even with aggressive growth at Anduril, the gap in absolute terms remains enormous.
The key driver is the comparison base. Lockheed Martin is a mature defense prime with revenue above $65bn and a stable market cap; its value fluctuates within a wide but known range. Anduril was valued in the tens of billions at recent rounds, and to catch Lockheed it would need a multiple re-rating of its private valuation, requiring new mega-rounds and favorable conditions. Our model puts Lockheed at 88%.
The market may be underpricing Lockheed because of hype around defense startups and news of Anduril contracts. For Lockheed to win, it is enough that its market cap stays above Anduril's private valuation at year-end — a scenario that holds absent an extraordinary Anduril round and absent a collapse in Lockheed shares.
The main risks are a sharp drop in Lockheed's capitalization (for example on F-35 program problems or budget cuts) combined with explosive growth in Anduril's valuation in a new round. Resolution methodology also matters: if the source is Anduril's private valuation rather than public trading, outcome volatility rises. The idea is invalidated by publication of an Anduril valuation above Lockheed's market cap.
Not investment advice. Trade at your own risk.